Skip to main navigation
Allakos Logo

Investors

Committee Composition

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Dan Janney Compensation Committee Nominating and Corporate Governance Committee
Robert Andreatta Audit Committee
Steven P. James Audit Committee Nominating and Corporate Governance Committee
Amy Ladd, MD Compensation Committee Nominating and Corporate Governance Committee
John McKearn, PhD Compensation Committee Nominating and Corporate Governance Committee
Paul Walker, CFA Audit Committee Compensation Committee
= Chairperson = Member = Chairman of the Board


(Common Stock)


March 25, 2023 12:29 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Toolkit

Print Page

Email Page

Email Alerts

RSS Feeds

  • IR Home
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory
  • Science
    • Overview
    • Biology
    • Siglec-8
    • Siglec-6
    • Lirentelimab (AK002)
    • AK006
    • Scientific Presentations
  • Clinical
    • Overview
    • Lirentelimab in Mast Cell and Eosinophil Driven Diseases
  • Patients
    • Allakos Commitment
    • EGID Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • Financials & Filings
      • SEC Filings
      • Quarterly Reports
      • Annual Reports
    • Stock Information
      • Stock Information
    • Contact
  • Careers
    • Working at Allakos
    • Open Positions
  • Contact
  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory
  • Science
    • Overview
    • Biology
    • Siglec-8
    • Siglec-6
    • Lirentelimab (AK002)
    • AK006
    • Scientific Presentations
  • Clinical
    • Overview
    • Lirentelimab in Mast Cell and Eosinophil Driven Diseases
  • Patients
    • Allakos Commitment
    • EGID Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • Financials & Filings
      • SEC Filings
      • Quarterly Reports
      • Annual Reports
    • Stock Information
      • Stock Information
    • Contact
  • Careers
    • Working at Allakos
    • Open Positions
  • Contact
©  Allakos Inc. All rights reservedWebsite Design: Hane Chow, Inc.
  • Privacy and Cookie Policy
  • Terms of Use